Sanofi Pays $2.4M To Kill Cancer Drug Sales Class Action
By Jeannie O'Sullivan (September 4, 2015, 7:38 PM EDT) -- Sanofi-Aventis US LLC has agreed to pay $2.4 million to employees who alleged the pharmaceutical giant shorted them commission payments from sales of the cancer drug Zaltrap, according to a preliminary settlement filed Friday in federal court in New Jersey
Lead plaintiffs Lisa Overton and Merribeth Bazzell had claimed in a putative class action that Sanofi refused to fully compensate Zaltrap sales representatives months after they exceeded expectations, despite repeated reassurances that the company would not change its sales incentive program.
The class represented Sanofi employees who received commissions, bonuses or other compensation from Zaltrap sales during the third and fourth...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!